JAMDA
Volume 12, Issue 1 , Pages 1-7, January 2011

Alzheimer’s Disease: Future Treatments

  • John E. Morley, MB, BCh

      Affiliations

    • Corresponding Author InformationAddress correspondence to John E. Morley, MB, BCh, Division of Geriatric Medicine, Saint Louis University School of Medicine, 1402 S. Grand Boulevard, M238, St. Louis, MO 63104.

Division of Geriatric Medicine, Saint Louis University School of Medicine, and GRECC, VA Medical Center, St. Louis, MO

published online 06 December 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J.E.M. is a patent holder for antisenses to amyloid precursor protein and a shareholder in Edunn Biopharmaceuticals.

PII: S1525-8610(10)00384-1

doi:10.1016/j.jamda.2010.10.008

JAMDA
Volume 12, Issue 1 , Pages 1-7, January 2011

Article Tools

* Image Usage & Resolution